Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting?

April 26, 2017antiarrhythmic Artery atrial bypass coronary DISCONTINUE fibrillation Grafting prescription drug therapy

0

Posted

When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting?

1 Answer

0

Posted

Author(s): Izhar U, Ad N, Rudis E, Milgalter E, Korach A, Viola N, Levi E, Asraff G, Merin G, Elami A Affiliation(s): Department of Cardiothoracic Surgery, Hadassah University Hospital, Jerusalem, Israel. izharu@bezeqint.net Publication date & source: 2005-02, J Thorac Cardiovasc Surg., 129(2):401-6. Publication type: Clinical Trial; Randomized Controlled Trial BACKGROUND: New-onset atrial fibrillation after coronary artery bypass grafting is common. Medical therapy includes various antiarrhythmic drugs to control heart rate and restore sinus rhythm. The purpose of this study was to determine the duration of antiarrhythmic therapy after discharge from the hospital. METHODS: One hundred twenty-nine patients in whom new atrial fibrillation after coronary artery bypass grafting developed and successfully reverted to sinus rhythm were prospectively randomized at dismissal to receive antiarrhythmic therapy for 1 week (group A; n = 44), 3 weeks (group B; n = 42), or 6 w